211 related articles for article (PubMed ID: 8898228)
1. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.
Hayman AR; Jones SJ; Boyde A; Foster D; Colledge WH; Carlton MB; Evans MJ; Cox TM
Development; 1996 Oct; 122(10):3151-62. PubMed ID: 8898228
[TBL] [Abstract][Full Text] [Related]
2. Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats.
Walters LM; Schneider GB
Bone Miner; 1988 Apr; 4(1):49-62. PubMed ID: 3056541
[TBL] [Abstract][Full Text] [Related]
3. Association of matrix acid and alkaline phosphatases with mineralization of cartilage and endochondral bone.
Roach HI
Histochem J; 1999 Jan; 31(1):53-61. PubMed ID: 10405823
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase knockout mice.
Hayman AR; Cox TM
J Bone Miner Res; 2003 Oct; 18(10):1905-7. PubMed ID: 14584904
[TBL] [Abstract][Full Text] [Related]
5. Role of tartrate-resistant acid phosphatase (TRAP) in long bone development.
Blumer MJ; Hausott B; Schwarzer C; Hayman AR; Stempel J; Fritsch H
Mech Dev; 2012 Jul; 129(5-8):162-76. PubMed ID: 22579636
[TBL] [Abstract][Full Text] [Related]
6. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
8. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
9. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
[TBL] [Abstract][Full Text] [Related]
10. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
Ortega N; Wang K; Ferrara N; Werb Z; Vu TH
Dis Model Mech; 2010; 3(3-4):224-35. PubMed ID: 20142327
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclastic bone resorption by mechanical stimulation in vitro.
Klein-Nulend J; Veldhuijzen JP; van Strien ME; de Jong M; Burger EH
Arthritis Rheum; 1990 Jan; 33(1):66-72. PubMed ID: 2302269
[TBL] [Abstract][Full Text] [Related]
13. New aspects of endochondral ossification in the chick: chondrocyte apoptosis, bone formation by former chondrocytes, and acid phosphatase activity in the endochondral bone matrix.
Roach HI
J Bone Miner Res; 1997 May; 12(5):795-805. PubMed ID: 9144346
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.
Valverde P; Zhang J; Fix A; Zhu J; Ma W; Tu Q; Chen J
J Bone Miner Res; 2008 Nov; 23(11):1775-88. PubMed ID: 18597627
[TBL] [Abstract][Full Text] [Related]
15. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
16. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
Minkin C
Calcif Tissue Int; 1982 May; 34(3):285-90. PubMed ID: 6809291
[TBL] [Abstract][Full Text] [Related]
17. Weight loading young chicks inhibits bone elongation and promotes growth plate ossification and vascularization.
Reich A; Jaffe N; Tong A; Lavelin I; Genina O; Pines M; Sklan D; Nussinovitch A; Monsonego-Ornan E
J Appl Physiol (1985); 2005 Jun; 98(6):2381-9. PubMed ID: 15677737
[TBL] [Abstract][Full Text] [Related]
18. Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.
Rice DP; Kim HJ; Thesleff I
Bone; 1997 Dec; 21(6):479-86. PubMed ID: 9430236
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast growth factor activity in medium conditioned by fetal rat bones.
Scheven BA; Hamilton NJ; Duncan A; Robins SP
Bone Miner; 1991 Sep; 14(3):221-35. PubMed ID: 1932894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
